Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IPX203 in advanced Parkinson's disease
NCT03007888Phase 2Completed
- Sponsor
- Impax Laboratories
- Start
- Nov 2016
- Primary completion
- Aug 2017
- Countries
- 1
01
Overview
A Phase 2 trial of levodopa + carbidopa in Parkinson's disease (PD), sponsored by Impax Laboratories. Started Nov 2016; status: completed.
02
Drugs
levodopa + carbidopa
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT03007888.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03007888.